SMIM22 and benign prostatic hyperplasia: The result demonstrated that CTSZ, GOLM1, SMIM22, FAM3B, TFF3, and PCA3 had higher expression, while FCGRT, ACPP, and MSMB had lower expression in PCa than BPH samples (Figure 4A).